Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira ®) in Healthy Adult Japanese Participants

Condition:   Healthy Volunteers Interventions:   Drug: ABP 501;   Drug: Adalimumab Sponsor:   Amgen Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials